The crosstalk between m6A RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling

被引:78
作者
Zhao, Yanchun [1 ]
Chen, Yunhao [2 ]
Jin, Mei [1 ]
Wang, Jin [1 ]
机构
[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol, Hangzhou 310000, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Surg,Div Hepatobiliary & Pancreat Surg, Hangzhou 310000, Peoples R China
关键词
N-6-methyladenosine (m(6)A); DNA methylation; chromatin remodeling; histone modification; non-coding RNA (ncRNA); RNA modification; METHYLTRANSFERASE METTL3 PROMOTES; MESSENGER-RNA; NONCODING RNA; NUCLEAR-RNA; M(6)A METHYLTRANSFERASE; COLORECTAL-CANCER; N-6-METHYLADENOSINE MODIFICATION; UNIQUE FEATURES; GENE-EXPRESSION; CIRCULAR RNAS;
D O I
10.7150/thno.54967
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Epigenetic regulation involves a range of sophisticated processes which contribute to heritable alterations in gene expression without altering DNA sequence. Regulatory events predominantly include DNA methylation, chromatin remodeling, histone modifications, non-coding RNAs (ncRNAs), and RNA modification. As the most prevalent RNA modification in eukaryotic cells, N-6-methyladenosine (m(6)A) RNA methylation actively participates in the modulation of RNA metabolism. Notably, accumulating evidence has revealed complicated interrelations occurring between m(6)A and other well-known epigenetic modifications. Their crosstalk conspicuously triggers epigenetic remodeling, further yielding profound impacts on a variety of physiological and pathological processes, especially tumorigenesis. Herein, we provide an up-to-date review of this emerging hot area of biological research, summarizing the interplay between m(6)A RNA methylation and other epigenetic regulators, and highlighting their underlying functions in epigenetic reprogramming.
引用
收藏
页码:4549 / 4566
页数:18
相关论文
共 174 条
[1]   Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase [J].
Akichika, Shinichiro ;
Hirano, Seiichi ;
Shichino, Yuichi ;
Suzuki, Takeo ;
Nishimasu, Hiroshi ;
Ishitani, Ryuichiro ;
Sugita, Ai ;
Hirose, Yutaka ;
Iwasaki, Shintaro ;
Nureki, Osamu ;
Suzuki, Tsutomu .
SCIENCE, 2019, 363 (6423) :141-141
[2]   HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events [J].
Alarcon, Claudio R. ;
Goodarzi, Hani ;
Lee, Hyeseung ;
Liu, Xuhang ;
Tavazoie, Saeed ;
Tavazoie, Sohail F. .
CELL, 2015, 162 (06) :1299-1308
[3]   N6-methyladenosine marks primary microRNAs for processing [J].
Alarcon, Claudio R. ;
Lee, Hyeseung ;
Goodarzi, Hani ;
Halberg, Nils ;
Tavazoie, Sohail F. .
NATURE, 2015, 519 (7544) :482-+
[4]   The interplay of epigenetic marks during stem cell differentiation and development [J].
Atlasi, Yaser ;
Stunnenberg, Hendrik G. .
NATURE REVIEWS GENETICS, 2017, 18 (11) :643-658
[5]   RNA ribose methylation (2′-O-methylation): Occurrence, biosynthesis and biological functions [J].
Ayadi, Lilia ;
Galvanin, Adeline ;
Pichot, Florian ;
Marchand, Virginie ;
Motorin, Yuri .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2019, 1862 (03) :253-269
[6]   LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma [J].
Ban, Yuanyuan ;
Tan, Pingqing ;
Cai, Jing ;
Li, Junjun ;
Hu, Meng ;
Zhou, Ying ;
Mei, Yan ;
Tan, Yixin ;
Li, Xiaoling ;
Zeng, Zhaoyang ;
Xiong, Wei ;
Li, Guiyuan ;
Li, Xiayu ;
Yi, Mei ;
Xiang, Bo .
MOLECULAR ONCOLOGY, 2020, 14 (06) :1282-1296
[7]   RNA Editing and Modifications in Mood Disorders [J].
Barbon, Alessandro ;
Magri, Chiara .
GENES, 2020, 11 (08) :1-17
[8]   VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer [J].
Barros-Silva, Daniela ;
Lobo, Joao ;
Guimaraes-Teixeira, Catarina ;
Carneiro, Isa ;
Oliveira, Jorge ;
Martens-Uzunova, Elena S. ;
Henrique, Rui ;
Jeronimo, Carmen .
CANCERS, 2020, 12 (04)
[9]   Small-Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer [J].
Bedi, Rajiv K. ;
Huang Danzhi ;
Eberle, Stefanie A. ;
Wiedmer, Lars ;
Sledz, Pawel ;
Caflisch, Amedeo .
CHEMMEDCHEM, 2020, 15 (09) :744-748
[10]   Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation [J].
Blagitko-Dorfs, Nadja ;
Schlosser, Pascal ;
Greve, Gabriele ;
Pfeifer, Dietmar ;
Meier, Ruth ;
Baude, Annika ;
Brocks, David ;
Plass, Christoph ;
Luebbert, Michael .
LEUKEMIA, 2019, 33 (04) :945-956